The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trial
Open accessAbstract
Gait and balance disturbances typically emerge in advanced Parkinson's disease with generally limited response to dopaminergic medication and subthalamic nucleus deep brain stimulation. Therefore, advanced programming with interleaved pulses was put forward to introduce concomittant nigral stimulation on caudal contacts of a subthalamic lead. Here, we hypothesized that the combined stimulation of subthalamic nucleus and substantia nigra pars reticulata improves axial symptoms compared with standard subthalamic nucleus stimulation. Twelve patients were enrolled in this 2 × 2 cross-over double-blind randomized controlled clinical trial and both the safety and efficacy of combined subthalamic nucleus and substantia nigra pars reticulata stimulation were evaluated compared with standard subthalamic nucleus stimulation. The primary outcome measure was the change of a broad-scaled cumulative axial Unified Parkinson's Disease Rating Scale score (Scale II items 13-15, Scale III items 27-31) at '3-week follow-up'. Secondary outcome measures specifically addressed freezing of gait, balance, quality of life, non-motor symptoms and neuropsychiatric symptoms. For the primary outcome measure no statistically significant improvement was observed for combined subthalamic nucleus and substantia nigra pars reticulata stimulation at the '3-week follow-up'. The secondary endpoints, however, revealed that the combined stimulation of subthalamic nucleus and substantia nigra pars reticulata might specifically improve freezing of gait, whereas balance impairment remained unchanged. The combined stimulation of subthalamic nucleus and substantia nigra pars reticulata was safe, and of note, no clinically relevant neuropsychiatric adverse effect was observed. Patients treated with subthalamic nucleus and substantia nigra pars reticulata stimulation revealed no 'global' effect on axial motor domains. However, this study opens the perspective that concomittant stimulation of the substantia nigra pars reticulata possibly improves otherwise resistant freezing of gait and, therefore, highly warrants a subsequent phase III randomized controlled trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
Kleiner-Fisman, G., Herzog, J., Fisman, D. N., Tamma, F., Lyons, K. E., Pahwa, R., Lang, A. E., & Deuschl, G. (2006) · Movement Disorders · doi:10.1002/mds.20962 · Cited by 957
Defective cortical drive to muscle in Parkinson's disease and its improvement with levodopa
Salenius, S., Avikainen, S., Kaakkola, S., Hari, R., & Brown, P. (2002) · Brain · doi:10.1093/brain/awf042 · Cited by 180 · cited 2×
“Whereas standard STN–DBS may primarily facilitate the thalamocortico-spinal motor control improving segmental symptoms (Salenius et al., 2002; Potter-Nerger et al., 2008; Kuriakose et al., 2010; Weiss et al., 2012a), gait disturbances in advanced disease stages may be associated with defective motor processing of mese…”
BackgroundAcute severe depression induced by intraoperative stimulation of the substantia nigra: a case report
Blomstedt, P., Hariz, M. I., Lees, A., Silberstein, P., Limousin, P., Yelnik, J., & Agid, Y. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.04.005 · Cited by 62 · cited 2×
“Previously, acute depressive (Bejjani et al., 1999; Blomstedt et al., 2008) or hypomanic clinical states (Ulla et al.”
Background
Cited by
Emerging therapies in Parkinson disease — repurposed drugs and new approaches
Elkouzi, A., Vedam-Mai, V., Eisinger, R. S., & Okun, M. S. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0155-7 · Cited by 300
Deep brain stimulation for Parkinson's disease
Hariz, M., & Blomstedt, P. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13541 · Cited by 256
A clinical view on the development of technology‐based tools in managing Parkinson's disease
Maetzler, W., Klucken, J., & Horne, M. (2016) · Movement Disorders · doi:10.1002/mds.26673 · Cited by 162
Deep Brain Stimulation: A Paradigm Shifting Approach to Treat Parkinson's Disease
Hickey, P., & Stacy, M. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00173 · Cited by 125
Emerging therapies for gait disability and balance impairment: Promises and pitfalls
Maetzler, W., Nieuwhof, F., Hasmann, S. E., & Bloem, B. R. (2013) · Movement Disorders · doi:10.1002/mds.25682 · Cited by 57
Metadata
- Authors
- Weiss, D., Walach, M., Meisner, C., Fritz, M., Scholten, M., Breit, S., Plewnia, C., Bender, B., Gharabaghi, A., Wächter, T., & Krüger, R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-06-11
- Volume
- 136
- Issue
- 7
- Pages
- 2098-2108
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2076087321
- Cited by
- 217
- References
- 3
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trial. https://app.cochat.ai/papers/10.1093/brain/awt122
- The paper
- Weiss, D., Walach, M., Meisner, C., Fritz, M., Scholten, M., Breit, S., Plewnia, C., Bender, B., Gharabaghi, A., Wächter, T., & Krüger, R. (2013). Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trial. Brain. https://doi.org/10.1093/brain/awt122
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.